SILVER GABRIELLE ALISON purchased 13.3% of their position (2.50K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $33.2K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/17/2022ACC: 0001385508-22-000062
Director
Since Jun 2019
+2.50K
Net shares
Net buyer
$33.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$13.29
Trade value
$33.22K
% of position
13.3%
5/16/2022
18.84K→21.34K
Total
Net shares
+2.50K
Net value
$33.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2022 | P · Purchase | +2.50K | $13.29 | $33.22K | 13.3% | 18.84K | 21.34K |
| Total | +2.50K | $33.22K | ||||||
Derivative Transactions0
No derivative transactions reported